GenericInsight.ai was founded with a clear mission: help generic pharmaceutical companies and off-patent originals win more tenders at better prices through AI-driven insights. Our team watched pharma companies struggle with finding the correct bid, often losing tenders, or cutting prices to unprofitable levels. We saw the uneven playingfield, where larger organizations had access to analytics which were out of reach for smaller actors. We knew there was a better way – one that combines deep industry know- how with the power of artificial intelligence.
About us
Empowering Generics with AI and Insight
The Problem We Solve
GenericInsight.ai tackles this challenge head-on. By focusing exclusively on tender pricing in Sweden, Finland and Denmark, we’ve developed an AI platform that turns complex data into simple, actionable guidance. We empower even the leanest pharma teams to make decisions with the confidence of a fully staffed analytics department with data scientists at the ready.
In national tender markets in Sweden, Finland and Denmark, pricing can make or break a pharma company. Yet many small and mid-sized manufacturers lack the data science resources of larger competitors. This leads to critical decisions made on gut feelings or limited data, resulting in missed opportunities. Knowledge of pricing and patterns are also often locked within specialists, which could be a vulnerability. Our AI makes sure you do not miss opportunities and makes sure the knowledge stays in your control.
Our Story
Founded in 2025 by a pharma expert, AI-expert and a development partner with the leading experts in machine learning, GenericInsight.ai was born out of real-world frustration and innovation.
When we saw too many tenders lost due to pricing guesswork, we partnered with our development partner to create a solution. The idea was simple: blend decades of tender experience with cutting-edge AI, and deliver it as an easy-to-use tool. No generic company should have to risk their margins or growth because they can’t afford an internal AI team.
Today, we remain a highly specialized company with a singular focus: price perfection for generics. Our small but agile team pours all our energy into refining algorithms, curating relevant data, and working closely with clients. We don’t try to be everything to everyone – we aim to be the best at what matters most to our clients: optimizing prices to win profitable tenders.
Overpricing
And losing valuable contracts to a competitor.
Underpricing
And winning deals that barely break even.
Uncertain Strategy
As market dynamics and competitor behaviors shift constantly after patent expiries and new entrants.
Our team
Nicholas Fernholm
Founder
Entrepreneur
Advisor Climatetrackerinitiative.com
AI-educator and strategic AI-consultant
Ludwig Kreisel
Advisor
Founder awra.se
Designed, developed and deployed several AI-solutions
Matthias Umpierrez
CTO
Founder awra.se
Designed, developed and deployed several AI-solutions
Dimitri Schritt
Ph.D. Data Scientist
ML Engineer
Senior Advisor and previous Post Doctoral Fellow at Osaka University
Specialization
We serve only the Pharma industry in the Nordics. This focus means our models and insights are deeply tuned to the nuances of Pharma markets and tender systems in the Nordics.
Innovation with Impact
We leverage AI in a practical, results-driven way. It’s not innovation for its own sake – it’s innovation that delivers measurable ROI, like the 10% performance boosts many of our clients have achieved.
Partnership Approach
We view our clients as partners. Your success in tenders is our success, and we work alongside you, providing support and expertise, to ensure you get the maximum value from our platform.
In Collaboration With
